Gosuranemab |
| Catalog No.GC72417 |
Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1788032-39-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Gosuranemab (BMS-986168) is a humanised IgG4 anti-tau monoclonal antibody. Gosuranemabbinds to human N-terminaltauresidues 15-22. Gosuranemab has the potential for the research of alzheimer’s disease (AD).
References:
[1]. Song C, et al. Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond. Transl Neurodegener. 2022 Mar 18;11(1):18.
[2]. Imbimbo BP, et al. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies. Alzheimers Dement. 2022 May;18(5):1008-1037.
Review for Gosuranemab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Gosuranemab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *